Fang Dong

1.5k total citations
62 papers, 778 citations indexed

About

Fang Dong is a scholar working on Hematology, Immunology and Molecular Biology. According to data from OpenAlex, Fang Dong has authored 62 papers receiving a total of 778 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Hematology, 27 papers in Immunology and 14 papers in Molecular Biology. Recurrent topics in Fang Dong's work include Hematopoietic Stem Cell Transplantation (28 papers), Immune Cell Function and Interaction (17 papers) and Acute Myeloid Leukemia Research (12 papers). Fang Dong is often cited by papers focused on Hematopoietic Stem Cell Transplantation (28 papers), Immune Cell Function and Interaction (17 papers) and Acute Myeloid Leukemia Research (12 papers). Fang Dong collaborates with scholars based in China, United States and Japan. Fang Dong's co-authors include Tao Cheng, Kehao Le, Sha Hao, Weiping Yuan, Hui Cheng, Shihui Ma, Yakun Pang, Yun Xia, Qiong Wang and Xiaoyun Xiao and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Fang Dong

54 papers receiving 775 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fang Dong China 15 340 259 215 187 168 62 778
Xinsheng Xie China 15 370 1.1× 167 0.6× 183 0.9× 151 0.8× 171 1.0× 72 726
Weijie Cao China 17 282 0.8× 227 0.9× 154 0.7× 116 0.6× 342 2.0× 64 817
Na Luo China 13 373 1.1× 126 0.5× 262 1.2× 180 1.0× 115 0.7× 22 715
Lenka Kubiczková Czechia 11 479 1.4× 107 0.4× 193 0.9× 159 0.9× 217 1.3× 17 782
Hind Medyouf Germany 13 526 1.5× 220 0.8× 247 1.1× 157 0.8× 298 1.8× 23 976
Yanxia Zhan China 17 230 0.7× 199 0.8× 300 1.4× 152 0.8× 84 0.5× 54 743
Ji Xu China 15 325 1.0× 169 0.7× 129 0.6× 214 1.1× 178 1.1× 50 641
Wanhong Zhao China 17 396 1.2× 322 1.2× 274 1.3× 196 1.0× 432 2.6× 54 978
Tim N. Beck United States 14 352 1.0× 99 0.4× 125 0.6× 151 0.8× 298 1.8× 28 756
James J. Ignatz-Hoover United States 12 379 1.1× 251 1.0× 124 0.6× 81 0.4× 273 1.6× 25 749

Countries citing papers authored by Fang Dong

Since Specialization
Citations

This map shows the geographic impact of Fang Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fang Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fang Dong more than expected).

Fields of papers citing papers by Fang Dong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fang Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fang Dong. The network helps show where Fang Dong may publish in the future.

Co-authorship network of co-authors of Fang Dong

This figure shows the co-authorship network connecting the top 25 collaborators of Fang Dong. A scholar is included among the top collaborators of Fang Dong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fang Dong. Fang Dong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Yue, Jingyuan Tong, Xiaorong Zhang, et al.. (2025). Leukemia-expanded splenic CD81+ erythroblasts potentiate disease progression in mice by reshaping leukemic cell metabolism. Journal of Clinical Investigation. 135(24).
2.
Chai, Yue, et al.. (2025). Development of an efficient differentiation culture system of murine HSC into megakaryocytes. Biochemical and Biophysical Research Communications. 752. 151463–151463.
4.
Dong, Fang, et al.. (2025). T Cell immune reconstitution after allo-HSCT: key factors and implications. PubMed. 7(4). e00261–e00261.
5.
Liu, Zixian, Jinhong Wang, Yao Ma, et al.. (2024). Early megakaryocyte lineage-committed progenitors in adult mouse bone marrow. SHILAP Revista de lepidopterología. 6(2). e00187–e00187. 2 indexed citations
6.
Sun, Huimin, Xueying Zhao, Aiming Pang, et al.. (2024). Monocytes as an early risk factor for acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Frontiers in Immunology. 15. 1433091–1433091. 1 indexed citations
8.
Zhou, Yabo, Dianheng Wang, Li Zhou, et al.. (2024). Cell softness renders cytotoxic T lymphocytes and T leukemic cells resistant to perforin-mediated killing. Nature Communications. 15(1). 1405–1405. 19 indexed citations
9.
Gao, Ai, Qing Li, Caiying Zhu, et al.. (2023). Interlukin-4 weakens resistance to stress injury and megakaryocytic differentiation of hematopoietic stem cells by inhibiting Psmd13 expression. Scientific Reports. 13(1). 14253–14253. 1 indexed citations
10.
Wu, Zhenghao, Junjie Zhou, Fang Dong, et al.. (2022). CD20+CD22+ADAM28+ B Cells in Tertiary Lymphoid Structures Promote Immunotherapy Response. Frontiers in Immunology. 13. 865596–865596. 39 indexed citations
11.
Zhang, Sen, Yao Ma, Lisha Wang, et al.. (2022). Expansion of Quiescent Hematopoietic Stem Cells under Stress and Nonstress Conditions in Mice. Stem Cell Reviews and Reports. 18(7). 2388–2402. 7 indexed citations
12.
Hu, Jin, Yanting Zhang, Fang Dong, et al.. (2022). The Effect of HER2 Status on Metaplastic Breast Cancer A Propensity Score-Matched Analysis. Frontiers in Endocrinology. 13. 874815–874815. 4 indexed citations
13.
Bai, Haitao, Sen Zhang, Jinhong Wang, et al.. (2022). Multiple cells of origin in common with various types of mouse N-Myc acute leukemia. Leukemia Research. 117. 106843–106843. 1 indexed citations
14.
Yan, Dong, Haitao Bai, Fang Dong, Xiao‐Bing Zhang, & Hideo Ema. (2021). Gene knockout in highly purified mouse hematopoietic stem cells by CRISPR/Cas9 technology. Journal of Immunological Methods. 495. 113070–113070. 7 indexed citations
15.
Dong, Fang, Shengnan Ruan, Jinlong Wang, et al.. (2020). M2 macrophage-induced lncRNA PCAT6 facilitates tumorigenesis and angiogenesis of triple-negative breast cancer through modulation of VEGFR2. Cell Death and Disease. 11(9). 728–728. 102 indexed citations
16.
Yu, Wenying, et al.. (2019). A Single-Cell Immunofluorescence Method for the Division Patterns Research of Mouse Bone Marrow-Derived Hematopoietic Stem Cells. Stem Cells and Development. 28(14). 954–960. 3 indexed citations
17.
Wang, Jinhong, Zixian Liu, Shanshan Zhang, et al.. (2019). Lineage marker expression on mouse hematopoietic stem cells. Experimental Hematology. 76. 13–23.e2. 13 indexed citations
18.
Dong, Fang, Sha Hao, Shihui Ma, et al.. (2016). A novel lymphoid progenitor cell population (LSKlow) is restricted by p18INK4c. Experimental Hematology. 44(9). 874–885.e5. 1 indexed citations
19.
Wang, Yajie, Chen Chen, Fang Dong, et al.. (2015). NK cells play a significant role in immunosurveillance at the early stage of MLL-AF9 acute myeloid leukemia via CD226/CD155 interactions. Science China Life Sciences. 58(12). 1288–1298. 9 indexed citations
20.
Dong, Fang, et al.. (1996). [Expression of c-erbB-2 oncogene and mutation of p53 gene in myoepithelioma and myoepithelial carcinoma].. PubMed. 31(2). 71–3. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026